Sarepta Shares Crash 25% After Third Patient Death Related Its Gene Therapy

zerohedge.com/markets/sarepta-shares-crash-25-after-third-patient-death-related-its-gene-therapy

Sarepta Shares Crash 25% After Third Patient Death Related Its Gene Therapy

Sarepta Therapeutics has confirmed a third patient death linked to its gene therapy programs, this time involving a 51-year-old man who died in June from acute liver failure after receiving the investigational…

This story appeared on zerohedge.com, 2025-07-18 14:40:00.
The Entire Business World on a Single Page. Free to Use →